home / stock / fbrx / fbrx news


FBRX News and Press, Forte Biosciences Inc. From 06/07/22

Stock Information

Company Name: Forte Biosciences Inc.
Stock Symbol: FBRX
Market: NASDAQ
Website: fortebiorx.com

Menu

FBRX FBRX Quote FBRX Short FBRX News FBRX Articles FBRX Message Board
Get FBRX Alerts

News, Short Squeeze, Breakout and More Instantly...

FBRX - Forte Biosciences appoints Dr. Hubert Chen as Chief Scientific Officer and President

Forte Biosciences (NASDAQ:FBRX) appoints Dr. Hubert Chen, MD as the Chief Scientific Officer and President. Prior to joining the company, Dr. Chen was the Chief Medical Officer of Metacrine. “Dr. Chen is a very accomplished drug development scientist and physician and we...

FBRX - Forte Biosciences GAAP EPS of -$0.17

Forte Biosciences press release (NASDAQ:FBRX): Q1 GAAP EPS of -$0.17. Ended first quarter 2022 with ~$40M in cash and cash equivalents. For further details see: Forte Biosciences GAAP EPS of -$0.17

FBRX - Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update

- Forte Biosciences to Develop Novel Pipeline for the Treatment of Autoimmune Diseases - -Leadership Strengthened with Appointments of Stephen Doberstein, Ph.D. and Barbara Finck, M.D. to the Board of Directors- -Ended first quarter 2022 with approximately $40....

FBRX - Best Penny Stocks to Buy Today? 3 to Watch on May 3rd

What to Know About Buying Penny Stocks on May 3rd, 2022 After an interesting start to May for penny stocks and blue chips, there is a lot for investors to know right now. While morning gainers like Forte Biosciences Inc. ( NASDAQ: FBRX ) and SoundHound AI Inc. ( NASDAQ: SOUN ) a...

FBRX - BiomX: Undervalued With Multiple Upcoming Catalysts

Utilizing its proprietary BOLT and synthetic biology platforms, BiomX develops natural and engineered phage therapeutic cocktails to treat chronic diseases ranging from acne, IBD, PSC, CF, A. Dermatitis and colorectal cancer. BiomX currently has four Phase 2 clinical trial readouts du...

FBRX - Kadmon, Adagio top weakly healthcare gainers; Forte Biosciences and Humanigen trail

Healthcare stocks in the S&P 500 underperformed the ~1.7% loss in the broader index to end ~2.7% lower over the holiday-shortened week to record their worst weekly performance since November. Among healthcare stocks with more than $300M market cap and over 100K average daily vol...

FBRX - ZIOPHARM Oncology, RenovoRx leads healthcare gainers; CorMedix, Sharecare among major losers

Gainers: ZIOPHARM Oncology (NASDAQ:ZIOP) +39%, RenovoRx (NASDAQ:RNXT) +17%, Sigilon Therapeutics (NASDAQ:SGTX) +17%, Acumen Pharmaceuticals (NASDAQ:ABOS) +15%, NeuroOne Medical Technologies (NASDAQ:NMTC) +7%. Losers: CorMedix (NASDAQ:CRMD) -25...

FBRX - Notable earnings before Tuesday's open

CMCM, COUP, FBRX, QTT For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Tuesday's open

FBRX - Wall Street Breakfast: What Moved Markets

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. The stock market closed the week on a relatively risk-off environment even with a much worse-than-expected number of jobs added to the econom...

FBRX - Catalyst watch for next week: GameStop and Affirm earnings, Coupang lock-up expiration, eyes on WKHS, SPRT, SYF

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Previous 10 Next 10